PFM Health Sciences, LP - Q4 2022 holdings

$2.79 Billion is the total value of PFM Health Sciences, LP's 89 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 47.1% .

 Value Shares↓ Weighting
HZNP  HORIZON THERAPEUTICS PUB L$124,251,392
+83.9%
1,091,8400.0%4.45%
+82.0%
CYTK SellCYTOKINETICS INC$109,947,152
-7.9%
2,399,545
-2.7%
3.94%
-8.9%
LLY  LILLY ELI & CO$109,255,555
+13.1%
298,6430.0%3.91%
+12.0%
MRK NewMERCK & CO INCcall$96,692,925871,500
+100.0%
3.46%
CNC  CENTENE CORP DEL$91,234,485
+5.4%
1,112,4800.0%3.27%
+4.3%
HUM  HUMANA INC$85,057,345
+5.6%
166,0660.0%3.05%
+4.5%
AXSM SellAXSOME THERAPEUTICS INC$84,290,055
+13.8%
1,092,831
-34.2%
3.02%
+12.7%
PEN  PENUMBRA INC$80,092,274
+17.3%
360,0300.0%2.87%
+16.1%
JNJ NewJOHNSON & JOHNSONput$79,492,500450,000
+100.0%
2.85%
UNH BuyUNITEDHEALTH GROUP INC$61,536,402
+9.2%
116,067
+4.0%
2.20%
+8.1%
RCUS SellARCUS BIOSCIENCES INC$55,903,975
-36.8%
2,703,287
-20.1%
2.00%
-37.5%
ABBV BuyABBVIE INC$53,225,284
+25.0%
329,344
+3.8%
1.91%
+23.8%
LH NewLABORATORY CORP AMER HLDGScall$52,983,000225,000
+100.0%
1.90%
PEN BuyPENUMBRA INCcall$52,834,250
+34.3%
237,500
+14.5%
1.89%
+33.0%
PRTA BuyPROTHENA CORP PLC$52,746,706
+3.5%
875,464
+4.2%
1.89%
+2.5%
QURE SellUNIQURE NV$52,193,458
+16.2%
2,302,314
-3.8%
1.87%
+15.1%
CAH  CARDINAL HEALTH INC$49,180,119
+15.3%
639,7830.0%1.76%
+14.1%
 OAK STR HEALTH INCnote 3/1$48,002,100
-1.7%
63,000,0000.0%1.72%
-2.8%
MOH  MOLINA HEALTHCARE INC$47,478,701
+0.1%
143,7790.0%1.70%
-0.9%
IQV  IQVIA HLDGS INC$46,936,406
+13.1%
229,0810.0%1.68%
+12.0%
CI  CIGNA CORP NEW$46,818,342
+19.4%
141,3000.0%1.68%
+18.2%
DHR  DANAHER CORPORATION$46,631,640
+2.8%
175,6900.0%1.67%
+1.7%
IRTC  IRHYTHM TECHNOLOGIES INC$46,246,846
-25.2%
493,7210.0%1.66%
-26.0%
SNDX BuySYNDAX PHARMACEUTICALS INC$46,182,435
+49.1%
1,814,634
+40.8%
1.65%
+47.5%
BIIB BuyBIOGEN INC$43,105,090
+15.9%
155,659
+11.7%
1.54%
+14.6%
MRK BuyMERCK & CO INC$40,788,992
+31.4%
367,634
+2.0%
1.46%
+30.1%
DVAX  DYNAVAX TECHNOLOGIES CORP$40,489,137
+1.9%
3,805,3700.0%1.45%
+0.9%
ARGX  ARGENX SEsponsored adr$39,675,624
+7.3%
104,7320.0%1.42%
+6.2%
MCK  MCKESSON CORP$39,691,822
+10.4%
105,8110.0%1.42%
+9.2%
EW BuyEDWARDS LIFESCIENCES CORP$39,545,538
-0.3%
530,030
+10.4%
1.42%
-1.4%
AZN  ASTRAZENECA PLCsponsored adr$39,107,040
+23.6%
576,8000.0%1.40%
+22.4%
SellBIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0$38,201,058
-16.2%
35,910,000
-21.8%
1.37%
-17.1%
UNH NewUNITEDHEALTH GROUP INCcall$36,900,52869,600
+100.0%
1.32%
ANTM BuyELEVANCE HEALTH INC$34,427,982
+193.8%
67,115
+160.1%
1.23%
+190.8%
TMO  THERMO FISHER SCIENTIFIC INC$34,221,529
+8.6%
62,1430.0%1.22%
+7.5%
AVTR SellAVANTOR INC$33,904,537
-16.8%
1,607,612
-22.7%
1.21%
-17.7%
PNT BuyPOINT BIOPHARMA GLOBAL INC$33,780,417
-3.2%
4,633,802
+2.6%
1.21%
-4.2%
WAT SellWATERS CORP$32,416,290
+2.2%
94,624
-19.6%
1.16%
+1.2%
BMRN SellBIOMARIN PHARMACEUTICAL INC$32,123,399
-66.0%
310,401
-72.2%
1.15%
-66.4%
ISRG NewINTUITIVE SURGICAL INC$30,369,308114,450
+100.0%
1.09%
SellCARIBOU BIOSCIENCES INC$28,007,437
-55.8%
4,459,783
-25.7%
1.00%
-56.2%
A NewAGILENT TECHNOLOGIES INC$27,461,374183,504
+100.0%
0.98%
KRTX  KARUNA THERAPEUTICS INC$25,602,575
-12.6%
130,2930.0%0.92%
-13.5%
BMRN BuyBIOMARIN PHARMACEUTICAL INCcall$25,148,070
+64.8%
243,000
+35.0%
0.90%
+63.0%
BCRX  BIOCRYST PHARMACEUTICALS INC$24,824,478
-8.9%
2,162,4110.0%0.89%
-9.8%
SGEN SellSEAGEN INC$24,723,268
-50.5%
192,384
-47.3%
0.88%
-51.1%
JNJ  JOHNSON & JOHNSON$24,332,831
+8.1%
137,7460.0%0.87%
+7.0%
AXSM NewAXSOME THERAPEUTICS INCcall$23,061,870299,000
+100.0%
0.83%
HCA SellHCA HEALTHCARE INC$22,063,122
-31.5%
91,945
-47.5%
0.79%
-32.2%
 PROCEPT BIOROBOTICS CORP$21,498,030
+0.2%
517,5260.0%0.77%
-0.8%
SellERASCA INC$20,677,053
-63.5%
4,797,460
-34.0%
0.74%
-63.9%
JAZZ NewJAZZ PHARMACEUTICALS PLCput$20,471,335128,500
+100.0%
0.73%
ISEE BuyIVERIC BIO INC$19,644,895
+327.2%
917,557
+258.0%
0.70%
+323.5%
NewARCELLX INC$19,099,635616,515
+100.0%
0.68%
UHS NewUNIVERSAL HLTH SVCS INCcl b$17,529,675124,421
+100.0%
0.63%
APLS BuyAPELLIS PHARMACEUTICALS INC$16,465,602
+97.8%
318,422
+161.3%
0.59%
+96.0%
ABBV NewABBVIE INCcall$16,161,000100,000
+100.0%
0.58%
BuyNEVRO CORPnote 2.750% 4/0$16,056,250
+88.5%
17,500,000
+94.4%
0.58%
+86.7%
CRL NewCHARLES RIV LABS INTL INC$15,867,47872,820
+100.0%
0.57%
ICLR SellICON PLC$15,875,081
-35.9%
81,725
-39.3%
0.57%
-36.6%
DXCM NewDEXCOM INC$15,340,057135,465
+100.0%
0.55%
EDIT BuyEDITAS MEDICINE INC$13,009,913
-16.9%
1,466,732
+14.7%
0.47%
-17.7%
THC SellTENET HEALTHCARE CORP$12,418,275
-55.8%
254,525
-53.3%
0.44%
-56.2%
LUNG BuyPULMONX CORP$12,272,141
+268.9%
1,455,770
+629.0%
0.44%
+265.8%
OSH SellOAK STR HEALTH INC$12,158,291
-31.4%
565,239
-21.8%
0.44%
-32.1%
GBIO SellGENERATION BIO CO$11,409,545
-28.7%
2,903,192
-3.7%
0.41%
-29.4%
THC NewTENET HEALTHCARE CORPcall$11,021,661225,900
+100.0%
0.40%
CELC BuyCELCUITY INC$9,976,675
+607.6%
712,111
+407.1%
0.36%
+600.0%
EPIX BuyESSA PHARMA INC$9,687,717
+260.1%
3,844,332
+160.1%
0.35%
+257.7%
PRTA BuyPROTHENA CORP PLCcall$9,176,075
+88.0%
152,300
+89.2%
0.33%
+85.9%
ADAP SellADAPTIMMUNE THERAPEUTICS PLCsponds adr$7,071,525
-29.4%
4,843,510
-48.0%
0.25%
-30.3%
PRAX SellPRAXIS PRECISION MEDICINES I$6,610,371
-15.8%
2,777,467
-19.7%
0.24%
-16.5%
BPMC  BLUEPRINT MEDICINES CORP$5,711,334
-33.5%
130,3660.0%0.20%
-34.1%
VERV SellVERVE THERAPEUTICS INC$4,204,794
-89.5%
217,302
-81.4%
0.15%
-89.6%
CMPS BuyCOMPASS PATHWAYS PLCsponsored ads$4,092,289
-4.1%
509,625
+28.1%
0.15%
-4.5%
LH NewLABORATORY CORP AMER HLDGS$3,193,34413,561
+100.0%
0.11%
PMVP SellPMV PHARMACEUTICALS INC$2,903,329
-71.5%
333,716
-61.0%
0.10%
-71.7%
HOWL SellWEREWOLF THERAPEUTICS INC$2,651,251
-79.1%
1,293,293
-54.1%
0.10%
-79.3%
BLUE NewBLUEBIRD BIO INC$1,694,480244,867
+100.0%
0.06%
ITOS SellITEOS THERAPEUTICS INC$1,385,107
-86.5%
70,922
-86.8%
0.05%
-86.5%
SellIO BIOTECH INC$1,167,572
-80.0%
507,640
-76.5%
0.04%
-80.2%
KROS NewKEROS THERAPEUTICS INC$768,27215,999
+100.0%
0.03%
XENE NewXENON PHARMACEUTICALS INC$689,55217,488
+100.0%
0.02%
BLU NewBELLUS HEALTH INC NEW$524,96263,864
+100.0%
0.02%
JNCE SellJOUNCE THERAPEUTICS INC$383,978
-96.0%
345,926
-91.6%
0.01%
-96.0%
SANA SellSANA BIOTECHNOLOGY INC$247,965
-94.0%
62,776
-90.9%
0.01%
-94.0%
VECT NewVECTIVBIO HLDG AG$221,31325,541
+100.0%
0.01%
NewBIOHAVEN LTD$152,51310,988
+100.0%
0.01%
IOVA NewIOVANCE BIOTHERAPEUTICS INC$85,22313,337
+100.0%
0.00%
ExitPARDES BIOSCIENCES INC$0-285,170
-100.0%
-0.02%
ZLAB ExitZAI LAB LTDadr$0-23,612
-100.0%
-0.03%
ExitSIGHT SCIENCES INC$0-227,692
-100.0%
-0.05%
ExitSOPHIA GENETICS SAordinary shares$0-879,913
-100.0%
-0.08%
JYAC ExitJIYA ACQUISITION CORP$0-464,103
-100.0%
-0.17%
BLSA ExitBCLS ACQUISITION CORP$0-464,103
-100.0%
-0.17%
ExitDYNAVAX TECHNOLOGIES CORPnote 2.500% 5/1$0-5,000,000
-100.0%
-0.23%
CANO ExitCANO HEALTH INC$0-776,893
-100.0%
-0.24%
OM ExitOUTSET MED INC$0-729,413
-100.0%
-0.42%
MYGN ExitMYRIAD GENETICS INC$0-742,138
-100.0%
-0.51%
NTLA ExitINTELLIA THERAPEUTICS INC$0-344,868
-100.0%
-0.70%
ICUI ExitICU MED INC$0-160,250
-100.0%
-0.87%
NVRO ExitNEVRO CORP$0-563,560
-100.0%
-0.95%
VEEV ExitVEEVA SYS INC$0-202,387
-100.0%
-1.21%
BIIB ExitBIOGEN INCcall$0-166,800
-100.0%
-1.61%
XLK ExitSELECT SECTOR SPDR TRput$0-383,500
-100.0%
-1.65%
ExitAERIE PHARMACEUTICALS INCnote 1.500%10/0$0-48,150,000
-100.0%
-1.71%
JAZZ ExitJAZZ PHARMACEUTICALS PLC$0-571,936
-100.0%
-2.76%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLINA HEALTHCARE INC41Q3 20232.2%
HCA HOLDINGS INC38Q3 20235.2%
HUMANA INC37Q3 20233.8%
EDWARDS LIFESCIENCES CORP36Q3 20233.3%
UNITEDHEALTH GROUP INC33Q3 20234.8%
PENUMBRA INC33Q3 20234.8%
AERIE PHARMACEUTICALS INC28Q2 20223.7%
TENET HEALTHCARE CORP27Q3 20232.3%
ELEVANCE HEALTH INC26Q3 20234.2%
ICON PLC26Q3 20232.5%

View PFM Health Sciences, LP's complete holdings history.

Latest significant ownerships (13-D/G)

View PFM Health Sciences, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-04-21

View PFM Health Sciences, LP's complete filings history.

Compare quarters

Export PFM Health Sciences, LP's holdings